Fig. 3
From: The gut metagenomics and metabolomics signature in patients with inflammatory bowel disease
Microbial biomarker analysis between IBD and healthy controls. A Cladogram of LEFSe analysis results in the IBD group; B LDA value distribution differentiating IBD group; C Relative abundance of the potential biomarker in the IBD group; D STAMP differential analysis of bacterial populations between the groups at the genus level